FLOGENZIM IN COMPLEX TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
The purpose of this drug to patients with initial and moderate symptoms of BPH in combination with traditional etiopathogenetic therapy along with good tolerability Flogenzim put in a number of particular relevance of therapeutic and prophylactic use. The results obtained the efficiency and safety Flogenzima with BPH can be recommended for wider application in treatment of these patients.
Number of Views: 310
Related publications:
REPROGRAMMING EXPERIENCE OF BLOOD MONONUCLEAR CELLS INTO INDUCED PLURIPOTENT STEM CELLS (IPSCS) IN A PATIENT WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)
CREATION OF THE PREGNANCY MICE MODEL TO STUDY THE EFFECT OF GLP-1/GIP AGONISTS
SATISFACTION WITH THE QUALITY OF PRIMARY CARE FOR PATIENTS WITH HYPERTENSION
BRUCELLA SPP. ANTIGENS IMPACT IN THE PATHOGENESIS AND DIAGNOSIS OF HUMAN BRUCELLOSIS
EPIDEMIOLOGY, RESOURCE DISTRIBUTION, AND MANAGEMENT CHALLENGES OF CHRONIC HEART FAILURE IN KAZAKHSTAN: A NATIONAL RETROSPECTIVE ANALYSIS